US0029421007
US0029421007
Aardvark Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 62.725.000 | 22.668.000 | 176.7% | |
| Operating Income | -62.725.000 | -22.668.000 | 176.7% |
| Pretax Income | -57.591.000 | -20.588.000 | 179.7% |
| Net Income Common Stockholders | -57.591.000 | -20.588.000 | 179.7% |
| -- | -- | -- | |
| -- | -- | -- |